In addition, extra-cerebral metastatic disease (RR: 1.52, p = 0.071) and time between breast cancer diagnosis and WBRT (RR: 1.37, p = 0.070) showed a trend.
← all excerpts
A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.
1
—
—